col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Frontiers Media SA: Frontiers in Molecular Biosciences
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis Fanwu Gong, Hua-xing Wei, Qiangsheng Li, Liu Liu, Bofeng Li
2 [GO] 2021―Jul―22 Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center David Barros Coelho, Vanessa Santos, David Araújo, Hélder Novais Bastos, Adriana Magalhães, Venceslau Hespanhol, et al. (+3)
3 [GO] 2021―Jul―21 The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge Yan-yan Yan, Wen-min Zhou, Yu-qing Wang, Qiao-ru Guo, Fu-xi Zhao, Zhuang-yan Zhu, et al. (+6)
4 [GO] 2021―Jul―20 A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19 Ruy Freitas Reis, Alexandre Bittencourt Pigozzo, Carla Rezende Barbosa Bonin, Barbara de Melo Quintela, Lara Turetta Pompei, Ana Carolina Vieira, et al. (+4)
5 [GO] 2021―Jul―12 Correlation Analysis Between Serum Uric Acid, Prealbumin Level, Lactate Dehydrogenase, and Severity of COVID-19 Zhenmu Jin, Mo Zheng, Jichan Shi, Xinchun Ye, Fang Cheng, Que-Lu Chen, et al. (+2)
6 [GO] 2021―Jul―12 Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19 M. Ramesh, Krishnan Anand, Mohd Shahbaaz, Magda H. Abdellattif
7 [GO] 2021―Jul―12 Mathematical Model of SARS-Cov-2 Propagation Versus ACE2 Fits COVID-19 Lethality Across Age and Sex and Predicts That of SARS Ugo Bastolla
8 [GO] 2021―Jul―09 Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline Edmond Y. Lau, Oscar A. Negrete, W. F. Drew Bennett, Brian J. Bennion, Monica Borucki, Feliza Bourguet, et al. (+25)
9 [GO] 2021―Jul―05 In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19 Muthumanickam Sankar, Balajee Ramachandran, Boomi Pandi, Nachiappan Mutharasappan, Vidhyavathi Ramasamy, Poorani Gurumallesh Prabu, et al. (+9)
10 [GO] 2021―Jul―02 Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study Sankar Muthumanickam, Arumugam Kamaladevi, Pandi Boomi, Shanmugaraj Gowrishankar, Shunmugiah Karutha Pandian
11 [GO] 2021―Jul―01 Management and Thinking on the Treatment of Cancer Patients During the COVID-19 Shuangyue Pan, Jiahong Jiang, Zheling Chen, Liu Yang
12 [GO] 2021―Jun―30 The Role of Indoor Plants in air Purification and Human Health in the Context of COVID-19 Pandemic: A Proposal for a Novel Line of Inquiry Rania El-Tanbouly, Ziad Hassan, Sarah El-Messeiry
13 [GO] 2021―Jun―21 Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2 Santosh K. Ghosh, Aaron Weinberg
14 [GO] 2021―Jun―11 Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer Jingwen Yue, Weihua Jin, Hua Yang, John Faulkner, Xuehong Song, Hong Qiu, et al. (+5)
15 [GO] 2021―Jun―09 A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials Jeyanthi Venkadapathi, Venkat Kumar Govindarajan, Saravanan Sekaran, Santhi Venkatapathy
16 [GO] 2021―Jun―09 In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2 Edoardo Milanetti, Mattia Miotto, Lorenzo Di Rienzo, Madhu Nagaraj, Michele Monti, Thaddeus W. Golbek, et al. (+5)
17 [GO] 2021―Jun―04 Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients Hongliang Zhang, Yujie Tang, Jinhui Tao
18 [GO] 2021―May―31 Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection Arnaud John Kombe Kombe, Ayesha Zahid, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin
19 [GO] 2021―May―26 Initial PCR Testing Negative, but Chest CT Suggesting for Viral Pneumonia Urges for Repeated Testing for COVID-19 Diagnosis Lingwei Wang, Danting Zhan, Xiaodi Liu, Kai Yang, Shipin Wu, Heng Zhang, et al. (+6)
20 [GO] 2021―May―26 Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach Mycal Dutta, Mohammad Nezam, Subrata Chowdhury, Ahmed Rakib, Arkajyoti Paul, Saad Ahmed Sami, et al. (+8)
21 [GO] 2021―May―24 The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19 Hao Li, Jianmin Li, Wei Xiao, Yujing Zhang, Yuan Lv, Xing Yu, Jiao Zheng
22 [GO] 2021―May―24 Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study Sonia Beeckmans, Edilbert Van Driessche
23 [GO] 2021―May―17 An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease Tianhua Zhai, Fangyuan Zhang, Shozeb Haider, Daniel Kraut, Zuyi Huang
24 [GO] 2021―May―13 Current Strategies of Antiviral Drug Discovery for COVID-19 Miao Mei, Xu Tan
25 [GO] 2021―May―11 Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2 Perumal Gobinath, Ponnusamy Packialakshmi, Daoud Ali, Saud Alarifi, Amal Alotaibi, Akbar Idhayadhulla, Radhakrishnan Surendrakumar
26 [GO] 2021―May―10 Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2 Shafi Mahmud, Gobindo Kumar Paul, Suvro Biswas, Shamima Afrose, Mohasana Akter Mita, Md. Robiul Hasan, et al. (+9)
27 [GO] 2021―May―10 Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications Nadide Altincekic, Sophie Marianne Korn, Nusrat Shahin Qureshi, Marie Dujardin, Martí Ninot-Pedrosa, Rupert Abele, et al. (+123)
28 [GO] 2021―May―05 A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein Maria Luisa Di Vona, Gian Maria Rossolini, Marco Sette
29 [GO] 2021―Apr―22 Antibodies and Vaccines Target RBD of SARS-CoV-2 Long Min, Qiu Sun
30 [GO] 2021―Apr―20 Impact of Ribosome Activity on SARS-CoV-2 LNP - Based mRNA Vaccines Evangelos Tsiambas, Aristeidis Chrysovergis, Vasileios Papanikolaou, Nicholas Mastronikolis, Vasileios Ragos, Anna Batistatou, et al. (+4)
31 [GO] 2021―Apr―15 Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19 Rajashri Bezbaruah, Pobitra Borah, Bibhuti Bhushan Kakoti, Nizar A. Al-Shar’I, Balakumar Chandrasekaran, Da’san M. M. Jaradat, et al. (+2)
32 [GO] 2021―Apr―15 Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6 Pan Li, Zhengmao Lu, Qiang Li, Zhenmeng Wang, Yan Guo, Chen Cai, et al. (+12)
33 [GO] 2021―Apr―13 High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China Jun Duan, Jia Zeng, Puyu Deng, Zhong Ni, Rongli Lu, Wenxi Xia, et al. (+5)
34 [GO] 2021―Apr―13 Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production Xiaohui Zhao, Huan Chen, Hongliang Wang
35 [GO] 2021―Apr―12 Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19 Yun Yang, Weishan Huang, Yubo Fan, Guo-Qiang Chen
36 [GO] 2021―Apr―12 Inhibition of SARS-CoV-2 3CL Mpro by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19 Anwar Ullah, Kifayat Ullah
37 [GO] 2021―Apr―12 The Deadly Duo of COVID-19 and Cancer! Vivek R. Bora, Bhoomika M. Patel
38 [GO] 2021―Apr―09 Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2 Thirumal Kumar D, Nishaat Shaikh, Udhaya Kumar S, George Priya Doss C, Hatem Zayed
39 [GO] 2021―Mar―31 A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study Srichandan Padhi, Samurailatpam Sanjukta, Rounak Chourasia, Rajendra K. Labala, Sudhir P. Singh, Amit K. Rai
40 [GO] 2021―Mar―30 Chest CT Images for COVID-19: Radiologists and Computer-Based Detection Qingli Dou, Jiangping Liu, Wenwu Zhang, Yanan Gu, Wan-Ting Hsu, Kuan-Ching Ho, et al. (+3)
41 [GO] 2021―Mar―25 Perspectives on RNA Vaccine Candidates for COVID-19 Pobitra Borah, Pran Kishore Deb, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Katharigatta N. Venugopala, Vinayak Singh, et al. (+5)
42 [GO] 2021―Mar―18 Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression Etienne Cavalier, Julien Guiot, Katharina Lechner, Alexander Dutsch, Mark Eccleston, Marielle Herzog, et al. (+4)
43 [GO] 2021―Mar―16 An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus Muthu Kumaradoss Kathiravan, Srimathi Radhakrishnan, Vigneshwaran Namasivayam, Senthilkumar Palaniappan
44 [GO] 2021―Mar―08 Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives Karthik Vivekanandhan, Poornima Shanmugam, Hamed Barabadi, Vigneshwaran Arumugam, Dharun Daniel Raj Daniel Paul Raj, Manikandan Sivasubramanian, et al. (+6)
45 [GO] 2021―Feb―26 Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection Biswa Mohan Sahoo, B. V. V. Ravi Kumar, J. Sruti, Manoj Kumar Mahapatra, Bimal K. Banik, Preetismita Borah
46 [GO] 2021―Feb―22 Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection Elettra Barberis, Virginia V. Vanella, Marco Falasca, Valeria Caneapero, Giuseppe Cappellano, Davide Raineri, et al. (+14)
47 [GO] 2021―Feb―20 Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, Manoj Goyal, Monika Bansal, Snawar Hussain, et al. (+5)
48 [GO] 2021―Feb―15 Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin Mattia Miotto, Lorenzo Di Rienzo, Leonardo Bò, Alberto Boffi, Giancarlo Ruocco, Edoardo Milanetti
49 [GO] 2021―Feb―08 New Insights Into Potential Benefits of Bioactive Compounds of Bee Products on COVID-19: A Review and Assessment of Recent Research Ehab Kotb Elmahallawy, Yasser Mohamed, Walied Abdo, Fatma A. El-Gohary, Shaimaa Ahmed Awad Ali, Tokuma Yanai
50 [GO] 2021―Feb―04 Therapeutic Strategies in the Management of COVID-19 Rajashri R. Naik, Ashok K. Shakya
51 [GO] 2021―Jan―27 SARS-CoV-2 Proteins Exploit Host’s Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam
52 [GO] 2021―Jan―25 Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic Mingjia Yu, Tianji Zhang, Wei Zhang, Qianyun Sun, Hongmei Li, Jin-ping Li
53 [GO] 2021―Jan―25 A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic Tofael Ahmed Sumon, Md. Ashraf Hussain, Md. Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, et al. (+5)
54 [GO] 2021―Jan―19 In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19 Divya M. Teli, Mamta B. Shah, Mahesh T. Chhabria
55 [GO] 2021―Jan―14 In vitro Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19 Thirupathi Dongala, Naresh Kumar Katari, Santhosh Kumar Ettaboina, Anand Krishnan, Murtaza M. Tambuwala, Kamal Dua
56 [GO] 2021―Jan―13 Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels Hao Chen, Rundong Qin, Zhifeng Huang, Li He, Wenting Luo, Peiyan Zheng, et al. (+3)
57 [GO] 2021―Jan―13 SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells Shiv Bharadwaj, Mahendra Singh, Nikhil Kirtipal, Sang Gu Kang
58 [GO] 2021―Jan―07 Exploring the Potential of Carbon Dots to Combat COVID-19 Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil A. Alhakamy, Shadab Md, Anroop B. Nair, Pran Kishore Deb
59 [GO] 2021―Jan―07 The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, et al. (+2)
60 [GO] 2021―Jan―07 Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet™ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses Neelaveni Thangavel, Mohammad Al Bratty, Hassan Ahmad Al Hazmi, Asim Najmi, Reem Othman Ali Alaqi
61 [GO] 2020―Dec―23 Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro Savariar Vincent, Selvaraj Arokiyaraj, Muthupandian Saravanan, Manoj Dhanraj
62 [GO] 2020―Dec―23 Visual Detection of SARS-CoV-2 RNA by Conventional PCR-Induced Generation of DNAzyme Sensor Anbalagan Anantharaj, Soon Jyoti Das, Patil Sharanabasava, Rakesh Lodha, Sushil K. Kabra, Tarun Kumar Sharma, Guruprasad R. Medigeshi
63 [GO] 2020―Dec―18 Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line Alexander A. Dolskiy, Sergei A. Bodnev, Anastasia A. Nazarenko, Anastasia M. Smirnova, Olga G. Pyankova, Anna K. Matveeva, et al. (+7)
64 [GO] 2020―Dec―18 Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening Ashraf Ahmed Ali Abdusalam, Vikneswaran Murugaiyah
65 [GO] 2020―Dec―18 Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case Anushka Halder, Arinnia Anto, Varsha Subramanyan, Moitrayee Bhattacharyya, Smitha Vishveshwara, Saraswathi Vishveshwara
66 [GO] 2020―Dec―17 Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be Giuseppina Mariano, Rebecca J. Farthing, Shamar L. M. Lale-Farjat, Julien R. C. Bergeron
67 [GO] 2020―Dec―14 Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019 Yuanfeng Zhang, Zheyi Wang, Yue Zhang, Hongxuan Tong, Yiling Zhang, Tao Lu
68 [GO] 2020―Dec―11 A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein Rounak Chourasia, Srichandan Padhi, Loreni Chiring Phukon, Md Minhajul Abedin, Sudhir P. Singh, Amit Kumar Rai
69 [GO] 2020―Dec―11 Fetal Metabolomic Alterations Following Porcine Reproductive and Respiratory Syndrome Virus Infection Carolina M. Malgarin, Daniel J. MacPhee, John C. S. Harding
70 [GO] 2020―Dec―09 Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2 Yixin Xie, Chitra B. Karki, Dan Du, Haotian Li, Jun Wang, Adebiyi Sobitan, et al. (+3)
71 [GO] 2020―Dec―04 Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19 Wen Cui, Kailin Yang, Haitao Yang
72 [GO] 2020―Nov―24 Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM Md Fulbabu Sk, Nisha Amarnath Jonniya, Rajarshi Roy, Sayan Poddar, Parimal Kar
73 [GO] 2020―Nov―20 Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections Satyendra C. Tripathi, Vishwajit Deshmukh, Chad J. Creighton, Ashlesh Patil
74 [GO] 2020―Nov―17 Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil Abdulhafiz Alhakamy, Shadab Md, Anroop B. Nair, Pran Kishore Deb
75 [GO] 2020―Oct―23 Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis Jukun Song, Jing Han, Feng Liu, Xianlin Chen, Shenqi Qian, Yadong Wang, et al. (+4)
76 [GO] 2020―Oct―16 Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues Qiushi Feng, Lin Li, Xiaosheng Wang
77 [GO] 2020―Oct―16 Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations Soumya Lipsa Rath, Kishant Kumar
78 [GO] 2020―Oct―15 Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches Muhammad Waqas, Ali Haider, Muhammad Sufyan, Sami Siraj, Sheikh Arslan Sehgal
79 [GO] 2020―Oct―14 COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response Sanchit Seth, Jyotsna Batra, Srilakshmi Srinivasan
80 [GO] 2020―Oct―08 ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection? Francesca Pagliari, Maria Grazia Marafioti, Geraldine Genard, Patrizio Candeloro, Giuseppe Viglietto, Joao Seco, Luca Tirinato
81 [GO] 2020―Sep―30 Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy Zhongren Xu, Lixiang Yang, Xinghao Zhang, Qiling Zhang, Zhibin Yang, Yuanhao Liu, et al. (+2)
82 [GO] 2020―Sep―30 ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives Federica Saponaro, Grazia Rutigliano, Simona Sestito, Lavinia Bandini, Barbara Storti, Ranieri Bizzarri, Riccardo Zucchi
83 [GO] 2020―Sep―23 Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel Yipeng Cao, Rui Yang, Wei Wang, Imshik Lee, Ruiping Zhang, Wenwen Zhang, et al. (+3)
84 [GO] 2020―Sep―18 SARS-CoV-2 Virion Stabilization by Zn Binding Silvia Morante, Giovanni La Penna, Giancarlo Rossi, Francesco Stellato
85 [GO] 2020―Sep―10 Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches Rocktotpal Konwarh
86 [GO] 2020―Sep―01 Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses Luca Vangelista, Massimiliano Secchi
87 [GO] 2020―Aug―25 Drug Weaponry to Fight Against SARS-CoV-2 Elena Cabezón, Ignacio Arechaga
88 [GO] 2020―Aug―21 SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle Eleni Nikolakaki, Thomas Giannakouros
89 [GO] 2020―Aug―21 Bioactive Virus-Mimicking Nanovesicles From Dendrimersomes: A Novel Approach to Understanding SARS-CoV-2 Host-Interactions to Better Design Therapeutics Bilal Javed
90 [GO] 2020―Aug―11 Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19 Swapan K. Chatterjee, Snigdha Saha, Maria Nilda M. Munoz
91 [GO] 2020―Aug―11 COVID-19: Looking Into the Overlooked Fernanda Cristina Petersen, Ulf Reidar Dahle, Belinda Nicolau, Climent Casals-Pascual
92 [GO] 2020―Aug―07 Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19 Navin Kumar Verma, Mobashar Hussain Urf Turabe Fazil, Shane P. Duggan, Dermot Kelleher
93 [GO] 2020―Aug―04 Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease Yuliana K. Bosken, Timothy Cholko, Yuan-Chao Lou, Kuen-Phon Wu, Chia-en A. Chang
94 [GO] 2020―Aug―03 A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment Luciano Pirone, Annarita Del Gatto, Sonia Di Gaetano, Michele Saviano, Domenica Capasso, Laura Zaccaro, Emilia Pedone
95 [GO] 2020―Jul―03 Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19 Bicheng Zhang, Xiaoyang Zhou, Chengliang Zhu, Yuxiao Song, Fan Feng, Yanru Qiu, et al. (+5)
96 [GO] 2020―Jun―05 Does Early Childhood Vaccination Protect Against COVID-19? Karzan R. Sidiq, Dana Khdr Sabir, Shakhawan M. Ali, Rimantas Kodzius


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.016 sec